Real-World Study of the Treatment Patterns of Patients Diagnosed with Therapy-Related AML or AML-MRC in England between 2013 and 2020 Using the Cancer Analysis System Database

被引:0
|
作者
Legg, Alex [1 ]
Muzwidzwa, Ruvimbo [2 ]
Adamson, Elizabeth [2 ]
Wilkes, Emily [2 ]
Medalla, Greg [1 ]
机构
[1] Jazz Pharmaceut, Oxford, England
[2] IQVIA Inc, London, England
关键词
D O I
10.1182/blood-2021-148159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1248
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Real-World Treatment Patterns and Outcomes of Patients with Newly Diagnosed Multiple Myeloma: An Analysis Using National Health Insurance Service Database
    Lee, YooSun
    Yoon, Junghyun
    Park, Boyoung
    Eom, Hyeon-Seok
    BLOOD, 2022, 140 : 5156 - 5157
  • [22] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Mantle Cell Lymphoma in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Huang, Ruijian
    Xiao, Yue
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [23] A real-world study of treatment patterns among patients with osteoporotic fracture: analysis of a Japanese hospital database
    Hagino, Hiroshi
    Yoshinaga, Yoko
    Hamaya, Etsuro
    Lin, Tzu-Chieh
    Ajmera, Mayank
    Meyers, Juliana
    ARCHIVES OF OSTEOPOROSIS, 2023, 18 (01)
  • [24] A real-world study of treatment patterns among patients with osteoporotic fracture: analysis of a Japanese hospital database
    Hiroshi Hagino
    Yoko Yoshinaga
    Etsuro Hamaya
    Tzu-Chieh Lin
    Mayank Ajmera
    Juliana Meyers
    Archives of Osteoporosis, 18
  • [25] A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m+AML in Japan
    Kiguchi, Toru
    Sakurai, Masaya
    Tanaka, Yusuke
    Kuramoto, Kazuyuki
    Kado, Yuki
    Sawada, Sono
    Mitomi, Takeshi
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (11) : 1513 - 1522
  • [26] VENETOCLAX REAL-WORLD OBSERVATIONAL STUDY ON EFFECTIVENESS AND TREATMENT MANAGEMENT IN PATIENTS WITH NEWLY DIAGNOSED AML WHO ARE INELIGIBLE FOR INTENSIVE CHEMOTHERAPY IN ITALY - VERO
    Della Porta, M. G.
    Volpicelli, P.
    Caira, M.
    Malgieri, S.
    Nucciarelli, D.
    Gualberti, G.
    Finsinger, P.
    HAEMATOLOGICA, 2024, 109 : 89 - 89
  • [27] A post-hoc analysis of outcomes of patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) who received oral azacitidine (Oral-AZA) maintenance therapy in the QUAZAR AML-001 study
    Voso, Maria Teresa
    De Botton, Stephane
    Pfeilstocker, Michael
    Alvarez, Angela Figuera
    Wang, Kefeng
    See, Wendy L.
    Guerrero, Manuel Ugidos
    de Menezes, Daniel Lopes
    Petrlik, Erica
    Prebet, Thomas
    Roboz, Gail J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Real-World Treatment Patterns Among Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) with TP53 Mutation in the United States (US)
    Bystrom, Rebecca
    Fernandes, Laura L.
    Wynne, Joseph
    Pulte, Dianne
    Hansen, Eric
    Belli, Andrew J.
    Barcellos, Anna
    Zettler, Christina M.
    Vallejo, Jonathon
    Norsworthy, Kelly
    De Claro, Angelo
    Lerro, Catherine
    Theoret, Marc R.
    Wang, Ching-Kun
    Rivera, Donna
    BLOOD, 2023, 142
  • [29] Treatment intensity and survival trends among real-world elderly AML patients diagnosed in the period 2001-2016: a Danish nationwide cohort study
    Naur, Therese Maria Henriette
    Jakobsen, Lasse Hjort
    Roug, Anne Stidsholt
    El-Galaly, Tarec Christoffer
    Marcher, Claus Werenberg
    Norgaard, Jan Maxwell
    Theilgaard-Monch, Kim
    Moller, Peter
    Schollkopf, Claudia
    Severinsen, Marianne Tang
    LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 2014 - 2017
  • [30] REAL-WORLD TREATMENT PATTERNS AND PATIENT MANAGEMENT IN UNFIT PATIENTS WITH AML RECEIVING FIRST LINE SYSTEMIC TREATMENT OR BEST SUPPORTIVE CARE (CURRENT): ANALYSIS OF THE ITALIAN STUDY POPULATION
    Martelli, M. P.
    Olivieri, A.
    Di Renzo, N.
    Curti, A.
    Fracchiolla, N.
    Maurillo, L.
    Gualberti, G.
    Finsinger, P.
    D'Attino, R. M.
    Scalise, L.
    Ferrara, F.
    HAEMATOLOGICA, 2021, 106 (10) : 77 - 77